FBIOX Mutual Fund

FBIOX Mutual Fund (Fidelity Select Biotechnology Portfolio) is managed by Fidelity Investments (US) with $7.10B in net assets. FBIOX expense ratio is 0.62%, holding 191 positions across sectors including Health Care, Financials, Industrials. Inception date: 1985-12-16.

FBIOX performance shows a YTD return of 17.28%. The 1-year return is 53.49% and the 5-year return is 7.81%. FBIOX dividend yield stands at 5.78%, paid semi-annually.

FBIOX top holdings include Abbvie Inc. (13.2%), Krystal Biotech Inc (9.3%), Gilead Sciences (8.8%), Amgen Inc. (8.3%), Alnylam Pharmaceuticals Inc. (3.1%). Go to all FBIOX holdings, FBIOX sectors, or FBIOX dividends.

FBIOX can be compared against other funds. Use FBIOX overlap to find shared positions, or FBIOX vs another fund for a side-by-side view. FBIOX alternatives are available via the screener, along with tax-loss harvesting opportunities.